BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26248153)

  • 1. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation.
    Reiter MJ; Costello JE; Schwope RB; Lisanti CJ; Osswald MB
    J Comput Assist Tomogr; 2015; 39(6):825-34. PubMed ID: 26248153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular methods for the diagnosis of cancer.
    Cairns P; Sidransky D
    Biochim Biophys Acta; 1999 Mar; 1423(2):C11-8. PubMed ID: 10214347
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
    Bekci TT; Senol T; Maden E
    J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum chromogranin A is detectable in patients with carcinomas at advanced disease stages.
    Wu JT; Erickson AJ; Tsao KC; Wu TL; Sun CF
    Ann Clin Lab Sci; 2000 Apr; 30(2):175-8. PubMed ID: 10807161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor markers in hemodialysis patients.
    Arican A; Ozdemir N; Sezer S; Erten Y; Güz G; Turan M; Inanoglu I; Haberal M
    Transplant Proc; 1999 Dec; 31(8):3367-8. PubMed ID: 10616509
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
    Yu M; Wang YH; Abdalla AME; Liu WQ; Mei F; Wang J; Ouyang CX; Li YQ
    J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):722-728. PubMed ID: 25318883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of serum tumor markers for the early diagnosis of neoplasm and in health exams for asymptomatic persons].
    Bernabé Caro R; Moreno Nogueira JA
    Rev Clin Esp; 2002 Apr; 202(4):212-4. PubMed ID: 12003731
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring.
    Bidart JM; Thuillier F; Augereau C; Chalas J; Daver A; Jacob N; Labrousse F; Voitot H
    Clin Chem; 1999 Oct; 45(10):1695-707. PubMed ID: 10508114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor markers in gynecology].
    Alekseeva ML; Fanchenko ND; Novikov EA; Margiani FR
    Akush Ginekol (Mosk); 1995; (5):35-7. PubMed ID: 8579206
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumour markers.
    Pandha HS; Waxman J
    QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of tumor markers in childhood malignancies.
    Labdenne P; Heikinheimo M
    Ann Med; 2002; 34(5):316-23. PubMed ID: 12452476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.
    Kirwan A; Utratna M; O'Dwyer ME; Joshi L; Kilcoyne M
    Biomed Res Int; 2015; 2015():490531. PubMed ID: 26509158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary study.
    Turgutalp K; Ozhan O; Helvacı I; Ata A; Arican A; Boztepe B; Kıykım A
    Clin Chem Lab Med; 2013 Apr; 51(4):889-95. PubMed ID: 23314541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of obesity-related plasma hemodilution on serum tumor marker concentration in women.
    Park M; Chang IH; Kang H; Han SS
    J Obstet Gynaecol Res; 2015 May; 41(5):784-9. PubMed ID: 25421332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in the treatment of cancer: opportunities and pitfalls.
    Melichar B
    Clin Chem Lab Med; 2013 Jul; 51(7):1329-33. PubMed ID: 23729626
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumour markers with clinically controlled cut-offs for suspected cancer.
    Bosch X; Molina R; Marrades R; Augé JM; Pellicé M; López-Soto A
    Eur J Clin Invest; 2021 Jul; 51(7):e13523. PubMed ID: 33594702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interlaboratory surveys of the determination of tumour markers scatter and repeatability of the results.
    Kruse R; Geilenkeuser WJ; Röhle G
    Eur J Clin Chem Clin Biochem; 1993 Mar; 31(3):139-46. PubMed ID: 7683915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conventional serum tumor markers in liver cancer. Retrospective analysis of 118 patients].
    Arias-Flórez JS; Martínez-Delgado AM; Alarcón-Tarazona ML; Insuasty-Enriquez JS; Díaz-Martínez LA
    Rev Med Chil; 2018 Dec; 146(12):1422-1428. PubMed ID: 30848745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor markers in clinical practice: a review focusing on common solid cancers.
    Duffy MJ
    Med Princ Pract; 2013; 22(1):4-11. PubMed ID: 22584792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.